Virax Biolabs

Virax Biolabs (NASDAQ: VRAX) is a Biotech and disruptive Medical Technology company focused on the prevention, detection, and diagnosis of viral threats. 

Our mission is the global provision of high-quality diagnostic kits, particularly T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. 

Our proprietary diagnostic T-cell technologies are virus agnostic, offering high levels of transparency, information, and insight in a cost-efficient way.